|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ПсковГУ |
||
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trialстатья
Статья опубликована в высокорейтинговом журнале
Статья опубликована в журнале из списка Web of Science и/или Scopus- Авторы: Herbst Roy S., Wu Yi-Long, John Thomas, Grohe Christian, Majem Margarita, Wang Jie, Kato Terufumi, Goldman Jonathan W., Laktionov Konstantin
- Журнал: Journal of Clinical Oncology
- Том: 41
- Номер: 8
- Год издания: 2023
- Издательство: American Society of Clinical Oncology
- Местоположение издательства: United States
- DOI: 10.1200/JCO.22.02186
- Аннотация: Cancer surveillance is a field focused on collection of data to evaluate the burden of cancer and apply public health strategies to prevent and control cancer in the community. A key challenge facing the cancer surveillance community is the number of manual tasks required to collect cancer surveillance data, thereby resulting in possible delays in analysis and use of the information. To modernize and automate cancer data collection and reporting, the Centers for Disease Control and Prevention is planning, developing, and piloting a cancer surveillance cloud-based computing platform (CS-CBCP) with standardized electronic reporting from laboratories and health-care providers. With this system, automation of the cancer case collection process and access to real-time cancer case data can be achieved, which could not be done before. Furthermore, the COVID-19 pandemic has illustrated the importance of continuity of operations plans, and the CS-CBCP has the potential to provide such a platform suitable for remote operations of central cancer registries.
- Добавил в систему: Лактионов Константин Константинович